Clinical Trials Logo

Clinical Trial Summary

The trial studies the effects of personalized home-based aerobic and resistance exercises on quality of life, changes in physical activity levels, and the change in inflammatory myokines with the exercise intervention in Interleukin 6 (IL-6), C-reactive Protein (CRP), Leptin, Transforming growth factor beta (TGF-beta), and Interferon (INF) gamma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05103722
Study type Interventional
Source Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contact
Status Terminated
Phase N/A
Start date February 17, 2022
Completion date April 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05548621 - A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
Recruiting NCT04659343 - TDM for Optimized Outcome in Patients With mRCC.
Terminated NCT06377722 - Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer Phase 2
Completed NCT06161233 - Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy N/A
Not yet recruiting NCT06321250 - A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma Phase 1
Recruiting NCT04764487 - A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line Phase 3
Active, not recruiting NCT03905889 - A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma Phase 1
Recruiting NCT03977571 - Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial N/A
Completed NCT03699579 - Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC